Posts Tagged ‘cost

November 16, 2020
Our Take: Pfizer’s COVID-19 vaccine demonstrates more than 90% efficacy, early data show; Lilly’s antibody drug is first to receive EUA
Read More
November 09, 2020
Our Take: CMS approves controversial waiver, finalizes rules, penalizes hospitals for readmissions
Read More
November 02, 2020
Our Take: Intermountain Healthcare, Sanford Health to merge
Read More
October 26, 2020
Our Take: Health System Executive Survey — observations from the editor
Read More
October 19, 2020
Our Take: Increasingly concentrated health insurance markets may be harming consumers, providers, AMA study suggests
Read More
October 12, 2020
Our Take: Walmart introduces its health insurance agency, launches co-branded MA plans with Clover Health
Read More
October 05, 2020
Our Take: HHS, FDA finalize rule allowing states to import prescription drugs from Canada
Read More
September 28, 2020
Our Take: The Darwin Value Index
Read More
September 21, 2020
Our Take: MSSP generated net savings of $1.2 billion for Medicare in 2019
Read More
September 14, 2020
Our Take: Drug execs, public health officials try to shore up confidence in safety of future COVID-19 vaccine
Read More
August 31, 2020
Our Take: CDC changes COVID-19 testing guidance, FDA issues EUA for convalescent plasma; both agencies face backlash
Read More
August 24, 2020
Our Take: Big-name drugmakers make billion-dollar deals; digital ‘unicorn’ once worth $1.5 billion goes for $15 million
Read More
August 17, 2020
Our Take: As federal funding shores up for-profit health systems’ finances, lower utilization increases profits for Kaiser Permanente and top insurers
Read More
August 10, 2020
Our Take: Trump’s executive order, CMS’ proposed payment rules offer hope to rural areas
Read More

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Reach out to us

Gainey Corporate Center
8777 N Gainey Center Dr, Ste 205
Scottsdale, AZ 85258
(480) 923-0802

Sign up for Our Take
the weekly strategic brief for Health Care Executives

[contact-form-7 id="321" title="Footer Newsletter"]

Posts Tagged ‘cost

Our Take: Pfizer’s COVID-19 vaccine demonstrates more than 90% efficacy, early data show; Lilly’s antibody drug is first to receive EUA

Our Take: CMS approves controversial waiver, finalizes rules, penalizes hospitals for readmissions

Our Take: Intermountain Healthcare, Sanford Health to merge

Our Take: Health System Executive Survey — observations from the editor

Our Take: Increasingly concentrated health insurance markets may be harming consumers, providers, AMA study suggests

Our Take: Walmart introduces its health insurance agency, launches co-branded MA plans with Clover Health

Our Take: HHS, FDA finalize rule allowing states to import prescription drugs from Canada

Our Take: The Darwin Value Index

Our Take: MSSP generated net savings of $1.2 billion for Medicare in 2019

Our Take: Drug execs, public health officials try to shore up confidence in safety of future COVID-19 vaccine

Our Take: CDC changes COVID-19 testing guidance, FDA issues EUA for convalescent plasma; both agencies face backlash

Our Take: Big-name drugmakers make billion-dollar deals; digital ‘unicorn’ once worth $1.5 billion goes for $15 million

Our Take: As federal funding shores up for-profit health systems’ finances, lower utilization increases profits for Kaiser Permanente and top insurers

Our Take: Trump’s executive order, CMS’ proposed payment rules offer hope to rural areas

Sign up for Our Take
the weekly strategic brief for Health Care Executives

share

Reach out to us

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Stay Connected

Posts Tagged ‘cost

Sign up for Our Takethe weekly strategic brief for Health Care Executives

share

Reach out to us

Sign up for Our Takethe weekly strategic brief for Health Care Executives

Stay Connected

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Sign up for Our Take
the weekly strategic brief for Health Care Executives